Insys to Pay $225 Million to Settle Opioid-Sales Probe June 7, 2019 By Jef Feeley and Riley Griffin Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay...
